NCT06626867View on ClinicalTrials.gov

Effect of Dietary Fiber on Metabolic Syndrome, Gastrointestinal Function, Mood and Sleep Quality in Obese People

NACompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

May 8, 2022

Study Completion Date

December 31, 2022

Conditions
HypertensionHyperglycemiaDyslipidemiaObesityMetabolic Syndrome
Interventions
DIETARY_SUPPLEMENT

Dietary Fiber Supplementation

Each participant ingested either dietary fiber or placebo. The dietary fiber is indi-gestible dextrin (The WiseMan\'s Dining, KING CAR OTSUKA CO., Taipei, Taiwan). The dosage of contents in each package is 6 grams, 3 packs a day, with a total dose of 18 grams.

OTHER

Placebo

The placebo was a colored capsule with 5 grams of maltodextrin, which is taken once a day.

Trial Locations (1)

11153

Laboratory of Exercise Biochemistry, Department of Sports Sciences, University of Taipei, Taipei

All Listed Sponsors
lead

Chien-Wen Hou

OTHER

NCT06626867 - Effect of Dietary Fiber on Metabolic Syndrome, Gastrointestinal Function, Mood and Sleep Quality in Obese People | Biotech Hunter | Biotech Hunter